Weekly News Round-up – 24/4/20

This week saw a slight slowdown of the big news we’ve come to expect over the last few months, with only minor changes to the ever-shifting coronavirus front. That said, two of the Covid-19 treatment forerunners saw big announcements as...

5 years ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

Weekly News Round-up – 24/4/20

This week saw a slight slowdown of the big news we’ve come to expect over the last few months, with only minor changes to the ever-shifting coronavirus front. That said, two of the Covid-19 treatment forerunners saw big announcements as...

5 years ago

Weekly News Round-up – 17/4/20

This week, a glimpse of non-Covid normalcy is provided by news that a Tagrisso lung cancer study was unblinded early after ‘overwhelming accuracy’, potentially expanding the drug’s usage further. In other (Covid-related) news, GSK and Sanofi are set to collaborate...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 17/4/20

This week, a glimpse of non-Covid normalcy is provided by news that a Tagrisso lung cancer study was unblinded early after ‘overwhelming accuracy’, potentially expanding the drug’s usage further. In other (Covid-related) news, GSK and Sanofi are set to collaborate...

5 years ago

Weekly News Round-up – 9/3/20

In the news this week, everyone’s talking about this thing called ‘coronavirus’, not sure if you’ve heard of it. Gilead are set to donate 1.5 million doses of remdesivir to sick patients, while the Gates Foundation is preparing to spend...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 9/3/20

In the news this week, everyone’s talking about this thing called ‘coronavirus’, not sure if you’ve heard of it. Gilead are set to donate 1.5 million doses of remdesivir to sick patients, while the Gates Foundation is preparing to spend...

5 years ago

Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 years ago

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

5 years ago

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

5 years ago

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

5 years ago

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

5 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

5 years ago

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

5 years ago
Bioprocess,Clinical Development,R&D,Weekly Roundups

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

5 years ago

How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

5 years ago
Bioprocess,Biomanufacturing,News

How to Select a CMO in Biomanufacturing

Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...

5 years ago